A Study of the Combination of Raltitrexed and Irinotecan Every Two Weeks as 2nd Line Treatment of Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: Controlled:Raltitrexed and Irinotecan Primary outcome(s): Progression Free Survival Study Design: historical control
创建时间：
2012-11-15
